FDA offers eleventh-hour recall appeal
This article was originally published in Clinica
Executive Summary
The US FDA last week announced it was setting up an eleventh hour appeal mechanism for device manufacturers who want to challenge agency attempts to halt the distribution of products thought dangerous.